Moazzam Shahzad

12PUBLICATIONS
33CO-AUTHORS
Epidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 12, 2026
Externally Validated Machine Learning Models for 30-/90-/180-Day Unplanned Readmission After Head and Neck Cancer Hospitalizations in the United States.

|Oct 15, 2025
Outcomes with imetelstat in myelofibrosis: a systematic review and meta-analysis.

Moazzam Shahzad, Hafiz Muhammad Hannan Javed, Muhammad Shaheer Mannan

|Jun 13, 2025
Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.

James Yu, Jose M Laborde, Robin Park

|May 05, 2025
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines.

Aqeeb Ur Rehman, Fathima Shehnaz Ayoobkhan, Moazzam Shahzad

|Nov 20, 2024
What have we learned about TP53-mutated acute myeloid leukemia?

Moazzam Shahzad, Muhammad Kashif Amin, Naval G Daver

|Oct 25, 2022
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.

Moazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq

Pageof 2

Frequent Collaborators

7 joint publications

Muhammad Umair Mushtaq

3 joint publications

Faiz Anwer

3 joint publications

Muhammad Kashif Amin

3 joint publications

Joseph P McGuirk